Shining light on chest shielding
- PMID: 39090413
- DOI: 10.1038/s41390-024-03434-7
Shining light on chest shielding
Abstract
Impact: Key message: Chest shielding during phototherapy does not reduce the incidence of symptomatic PDA in preterm infants and does not affect phototherapy's efficacy. This study adds to the existing literature by providing a double-blinded RCT confirming previous inconsistent findings on the impact of chest shielding on PDA incidence. However, phototherapy may exert cardiovascular changes, including vasodilatation.
Impact: Chest shielding should not be recommended to be routinely performed in preterm infants during phototherapy.
© 2024. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.
Conflict of interest statement
Competing interests: The author declares no competing interests.
Comment on
-
Effect of chest shielding during phototherapy for hyperbilirubinemia on symptomatic patent ductus arteriosus - a double-blind randomized placebo-controlled trial.Pediatr Res. 2024 Dec;96(7):1771-1776. doi: 10.1038/s41390-024-03310-4. Epub 2024 Jun 22. Pediatr Res. 2024. PMID: 38909157 Clinical Trial.
References
-
- Mannan, J. & Amin, S. B. Effect of chest shielding during phototherapy for hyperbilirubinemia on symptomatic patent ductus arteriosus - a double-blind randomized placebo-controlled trial. Pediatr Res. https://doi.org/10.1038/s41390-024-03310-4 (2024). Epub ahead of print.
-
- Bhola, K., Foster, J. P. & Osborn, D. A. Chest shielding for prevention of a haemodynamically significant patent ductus arteriosus in preterm infants receiving phototherapy. Cochrane Database Syst. Rev. 11, CD009816 (2015).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
